
1251: Viewpoint Discrimination
Remdesivir Clinical Trials, COVID-19 Treatment Progress
Clinical trials for Remdesivir showed a statistically significant but modest 32% reduction in recovery time for hospitalized COVID-19 patients. Dr. Fauci expressed optimism that drug combinations might provide an effective treatment bridge before a vaccine is widely available.

